This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Americas

  1. The United States is among the largest funders of global health. As part of a global organization with a footprint in 70+ countries, the PATH team in Washington, D.C. leverages technical expertise to equip decision-makers with the information and evidence needed to make smart global health policy. In particular, we work with policymakers to ensure that funding for global health matches the scale of the challenges we face around the world, and that US global health polices and strategies are evidence-informed, ambitious, accountable, and—most importantly—promote equitable access to health. This brief gives a high-level overview of PATH as an organization, our impact, and our footprint in the United States.
    Published: August 2021
    Type: Resource Page
  2. The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria.
    Published: July 2021
    Type: Press Release
  3. This year’s annual report features our annual financial overview, a list of PATH’s funders and supporters, and our accomplishments in 2020.
    Published: July 2021
    Type: Resource Page
  4. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Type: Resource Page
  5. PATH’s mission is to advance health equity through innovation and partnerships. Central to this mission is gender equity, which requires fair treatment of all people regardless of sex, gender identity, or gender expression.Language matters, and in addressing gender equity, consistent terminology is important. The definitions contained in this glossary can be used in describing PATH’s work in a variety of programmatic contexts, including proposals, implementation plans, and monitoring and evaluation activities.The purpose of the document is to:Support global health workers in recognizing and understanding gender-related terms that are frequently used in health (and other sectors) programs.Contribute to a common interpretation and use of gender-related terms within and across PATH teams.Promote an informed application of gender-related terms in program initiatives and proposal development.
    Published: June 2021
    Type: Resource Page
  6. For more than 15 years, the M.J. Murdock Charitable Trust has partnered with PATH to improve public health capacity. This brief highlights a few examples of how the Murdock Trust has supported PATH’s in-house product development shop, helped strengthen digital health capabilities and even furthered the Primary Health Care (PHC) agenda. PATH is grateful for this long-standing partnership and the important public health work that it enables.
    Published: May 2021
    Type: Resource Page
  7. Local vaccine studies provide critical evidence to health officials, regulators, and manufacturers alike—but only a handful of sites worldwide are equipped to run them.
    Published: May 2021
    Type: Article
  8. "A new formulation entering clinical trials...could change how the world fights the pandemic," says Times article.
    Published: April 2021
    Type: Article
  9. The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2020 presenting a comprehensive look at the Global Fund grant cycle. The PCE assessed how business model factors have facilitated or hindered the achievement of objectives during implementation of grants approved during the 2017-19 funding cycle, including around Resilient and Sustainable Systems for Health (RSSH), sustainability and equity, and whether lessons learned during current grants have informed the next funding cycle. The objective of this grant cycle analysis was to understand what, when, why, and how grant investments change over time, including significant factors that influenced the implementation of and changes to the original grant.
    Published: February 2021
    Type: Resource Page
  10. PATH is a leader in adapting health innovations with and for women across systems, populations, and geographies. This brief outlines PATH's vision, approach, and areas of expertise in Sexual and Reproductive Health.
    Published: January 2021
    Type: Resource Page
Load more